Miehlen, Germany

Ulrich Werner

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 220(Granted Patents)


Location History:

  • Miehlen, DE (1994 - 2012)
  • Frankfurt-am-Main, DE (2010 - 2021)

Company Filing History:


Years Active: 1994-2021

where 'Filed Patents' based on already Granted Patents

21 patents (USPTO):

Title: Innovations by Ulrich Werner: Pioneering Advances in Pharmaceutical Conjugates

Introduction

Ulrich Werner, based in Miehlen, Germany, is a notable inventor with an impressive portfolio of 21 patents. His work primarily revolves around innovative pharmaceutical applications that enhance the efficacy of treatments through advanced biochemical formulations.

Latest Patents

Among his latest contributions to the field are two significant patents. The first patent focuses on insulin conjugates, which presents a novel conjugate comprising a sulfonamide and an active pharmaceutical ingredient, specifically an insulin analog. This analog features key mutations that enhance its functionality, specifically at positions B16 and B25 with hydrophobic amino acid substitutions. The second patent details conjugates of a pharmaceutical agent and a moiety capable of binding to glucose-sensing proteins. This innovation enables the reversible release of medications, depending on glucose concentrations, demonstrating the potential for improved diabetes management.

Career Highlights

Ulrich Werner has garnered valuable experience through his work with prominent pharmaceutical companies, including Sanofi-Aventis Deutschland GmbH and Sanofi-Aventis. His career has been marked by his dedication to advancing medical science through innovative drug formulations.

Collaborations

Throughout his career, Werner has collaborated with talented professionals such as Georg Tschank and Karl Schoenafinger. These partnerships have further enriched his research endeavors, contributing to the development of impactful pharmaceutical solutions.

Conclusion

Ulrich Werner's patent portfolio and innovative contributions signify his crucial role in the advancement of pharmaceutical sciences. His work on insulin conjugates and glucose-sensing drug delivery systems not only showcases his inventive spirit but also offers hope for improved therapeutic options in the field of diabetes treatment and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…